BALTIMORE--(BUSINESS WIRE)--Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback